Never miss important updates!
A South African based immunotherapy firm has developed Africa’s first Covid-19 vaccine - Shantivax.
The vaccines were designed and developed by scientists from GenLab based in Gqeberha, Eastern Cape.
The first Covid-19 vaccine in Africa - Shantivax - is being developed in SA by a Gqeberha-based company called GenLab. Image: Phill Magakoe / AFPSource: Getty Images
The vaccine prototype was developed in collaboration with a Danish company.
The vaccine is currently undergoing pre-clinical trials.
Reports say the South African vaccine will elicit both a T-cell and antibody response.
Read also
This will allow the body to identify and neutralise Covid-19.
Renergen, a South African renewables company, will be producing the Covid-19 vaccine storage unit soon.
The storage containers will contain helium to power an ultra-cold freezer.
Reports say the company is currently conducting discussions on the sale of the products.
The freezer can reportedly store up to 6 000 doses of the vaccine for up to 30 days.
Enjoyed reading our story?
Download BRIEFLY’s news app onGoogle Playnow and stay up-to-date with major South African news!
Source: Briefly News
Reeshni ChettyReeshni Chetty is a senior current affairs reporter.
Reeshni has a passion for breaking the stigma surrounding mental health issues.
